Intravaginal Prasterone (DHEA) (All Relevant Publications)

# FL Title Author(s) Year
117 1333 A Centralized Monitoring Approach Using Excel for the Quality Management of Clinical Trials. Published online, Applied Clinical Trials Online, Oct 26, 2015. Beauregard, A., Lavoie, L., Labrie, F. 2015
116 1310 Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspereunia and vaginal dryness, symptoms of vulvovaginal atrophy and of the genitourinary syndrome of menopause. Menopause, 23:243-256 Labrie, F., Archer, D. F., Koltun, W., Vachon, A., Young, D., Frenette, L., Portman, D. J., Montesino, M., Côté, I., Parent, J., Lavoie, L., Beauregard, A., Martel, C., Vaillancourt, M., Balser, J., Moyneur, É. et al 2016
115 1311 Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone). Menopause, 22:950-963. Archer, D. F., Labrie, F., Bouchard, C., Portman, D. J., Koltun, W., Cusan, L., Labrie, C., Côté, I., Lavoie, L., Martel, C., Balser, J. 2015
114 1213 Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy, Menopause, 16: 907-922. Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J.L., Girard, G., Baron, M., Ayotte, N., Moreau, M., Dubé, R., Côté, I., Labrie, C., Lavoie, L., Berger, L., Gilbert, L, Martel, C., Balser, J. 2009
113 1254 Intravaginal dehydroepiandrosterone (DHEA, Prasterone), a highly efficient treatment of dyspareunia. Climacteric, 14: 282-288. Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, JL., Girard, G., Baron, M., Ayotte, N., Moreau, M., Dubé, R., Côté, I, Labrie, C., Lavoie, L., Berger, L., Gilbert, L., Martel, C., Balser, J. 2011
112 1304 Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas, 81:46-56. Labrie, F., Archer, D.F., Bouchard, C., Girard, G., Ayotte, N., Gallagher, J.C., Cusan, L., Baron, M., Blouin, F., Waldbaum, A.S., Koltun, W., Portman, D.J., Côté, I., Lavoie, L., Beauregard, A., Labrie, C., Martel, C., Balser, J., Moyneur, E. et al 2015
111 1212 Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women, Menopause, 16: 923-931. Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J.L., Girard, G., Baron, M., Ayotte, N., Moreau, M., Dubé, R., Côté, I., Labrie, C., Lavoie, L., Berger, L., Gilbert, L, Balser, J. 2009
110 1319 Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy. J SEX MED, 12:2401-2412 Labrie, F., DeRogatis, L., Archer, D., Koltun, W., Vachon, A., Young, D., Frenette, L., Portman, D., Montesino, M., Côté, I., Parent, J., Lavoie, L., Beauregard, A., Martel, C., Vaillancourt, M., Balser, J., Moyneur, E. et al 2015
109 1320 Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study. HMBCI, 25:181-190 Bouchard, C., Labrie, F., Derogatis, L., Girard, G., Ayotte, N., Gallagher, J., Cusan, L., Archer, D., Portman, D., Lavoie, L., Beauregard, A., Côté, I., Martel, C., Vaillancourt, M., Balser, J., Moyneur, É. 2016
108 1288 Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women. J Sex Med, 11:1766-1785. Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J.L., Girard, G., Baron, M., Ayotte, N., Moreau, M., Dubé, R., Côté, I., Labrie, C., Lavoie, L., Gilbert, L., Martel, C. and Balser, J. 2014
107 1267 Predictors of sexual desire disorders in women. Journal of Sexual Medicine. 8:742-753 Brotto, L.A., Petkau, A.J., Labrie, F., Basson, R. 2011
106 1309 Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women. Menopause, Menopause, 22: 1289-1295. Portman, D. J., Labrie, F., Archer, D. F., Bouchard, C., Cusan, L., Girard, G., Ayotte, N., Koltun W., Blouin, F., Young, D., Wade, A., Martel, C. and Dubé, R. 2015
105 1189 Effect of Intravaginal DHEA on Serum DHEA and Eleven of its Metabolites in Postmenopausal Women. J Steroid Biochem Mol Biol, 111: 178-194 Labrie, F., Cusan, L., Gomez, J.L., Côté, I., Bérubé, R., Bélanger, P., Martel, C., Labrie, C. 2008
104 1190 Corrigendum to: Effect of Intravaginal DHEA on Serum DHEA and Eleven of its Metabolites in Postmenopausal Women. J Steroid Biochem Mol Biol, 112: 169 Labrie, F., Cusan, L., Gomez, J.L., Côté, I., Bérubé, R., Bélanger, P., Martel, C., Labrie, C. 2008
103 1211 Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration, Menopause, 16: 897-906. Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J.L., Girard, G., Baron, M., Ayotte, N., Moreau, M., Dubé, R., Côté, I., Labrie, C., Lavoie, L., Berger, L., Gilbert, L, Martel, C., Balser, J. 2009
102 1210 Effect of One-Week Treatment with Vaginal Estrogen Preparations on Serum Estrogen Levels in Postmenopausal Women. Menopause, 16: 30-36. Labrie, F., Cusan, L., Gomez, J.L., Côté, I., Bérubé, R., Bélanger, P., Martel, C., Labrie, C. 2009
101 1287 Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens. J Ster Biochem Mol Biol, 138:359-367 Labrie F, Martel C, Bérubé R, Côté I, Labrie C, Cusan L, Gomez JL. 2013
100 1317 Serum Levels of sex steroids and metabolites following 12-weeks of intravaginal DHEA administration. J Ster Biochem Mol Biol. 154:186-196. Ke, Y., Labrie, F., Gonthier, R., Simard, J.N., Bergeron, D., Martel, C., Vaillancourt, M., Montesino, M., Lavoie, L., Archer, D.F., Balser, J., Moyneur, É. et al. 2015
099 1318 Serum Steroids Remain Within the Same Normal Postmenopausal Values During 12-Month Intravaginal 0.50% DHEA. Horm Mol Biol Clin Invest, 24:117-129. Ke, Y., Gonthier, R., Simard, J.N., Archer, D., Lavoie, L., Martel, C., Vaillancourt, M. and Labrie, F. 2015
098 1231 Immunocytochemical localization of sex steroid hormone receptors in normal human mammary gland. J Histochem Cytochem. 58:509-15. Li, S., Han, B., Liu, G., Li, S., Ouellet, J., Labrie, F., Pelletier, G. 2010
097 1327 Letters to the Editor - No risk for the endometrium with intravaginal dehydroepiandrosterone. Menopause. 23:471-472 Portman, D.J., Archer, D.F., Martel, C., Labrie, F. 2016
096 1322 Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator. Gynecol Endocrinol, 32:240-245 Montesino, M., Labrie, F., Archer, D., Zerhouni, J., Côté, I., Lavoie, L., Beauregard, A., Martel, C., Vaillancourt, .M, Moyneur, É., Balser, J. 2016
095 1307 Influence of Treatment of Vulvovaginal Atrophy with Intravaginal Prasterone on the Male Partner. Climacteric. 18:817-825 Labrie, F., Montesino, M., Archer, D. F., Lavoie, L., Beauregard, A., Côté, I., Martel, C., Vaillancourt, M., Balser, J., Moyneur, É. et al 2015
094 1314 Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy. Climacteric, 18:590–607. Bouchard, C., Labrie, F., Archer, D.F., Portman, D.J., Koltun, W., Elfassi, E., Grainger, D.A., Ayotte, N., Cooper, T.A., Martens, M., Waldbaum, A.S., Labrie, C., Côté, I., Lavoie, L., Martel, C., Balser, J. et al. 2015
093 1316 RE: Is There a Correlation Between Androgens and Sexual Desire in Women? Letter to the Editor. J Sex Med. 12(7):1654-1655. Basson, R., Young, A., Brotto, L.A., Driscoll, M., Correia, S., Labrie, F. 2015
092 1315 Androgens in postmenopausal women : their practically exclusive intracrine formation and inactivation in peripheral tissues. In: Leo Plouffe and Botros R.M.B. Rizk (eds). Androgens in Gynecological Practice. Cambridge University Press, pp. 64-73, 2015. Labrie, F. 2015
091 1263 Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women. Clinical Endocrinology. 75:301-308. Johansson, P., Johansson, J.O., Labrie, F., Mattsson, N., Hansson, O., Blennow, K., Zetterberg, H., Wallin, A., Ohlsson, C., Svensson, J. 2011
090 1328 A validated LC-MS/MS method for the sensitive quantitation of serum 7alpha hydroxy-, 7beta hydroxy- and 7keto- dehydroepiandrosterone using a novel derivatization reagent. Steroids, 108:112-117. Ke, Y., Gonthier, R., Simard, J.N., Labrie, F. 2016
089 1330 Corrigendum to: A Sensitive, Simple and Robust LC-MS/MS Method for the Simultaneous Quantification of Seven Androgen- and Estrogen-Related Steroids in Postmenopausal Serum. JSBMB, 158: 231 Ke, Y., Bertin, J., Gonthier, R., Simard, J.N., Labrie, F. 2016
088 1292 A Sensitive Simple and Robust LC-MS/MS Method for the Simultaneous Quantification of Seven Androgen- and Estrogen-Related Steroid in Postmenopausal Serum. J Ster Biochem Mol Biol, 144:523-534. Ke, Y., Bertin, J., Gonthier, R., Simard, JN, Labrie F. 2014

Displaying results 1 to 30 out of 117

Page 1

Page 2

Page 3

Page 4

Next >